NEWS
2023
January 4:
A new publication with the group of Dr. Carine Wouters and Dr. Patrick Matthys on how cell-cell fusion and multinucleation reset differentiated macrophage identity in EMBO reports.
Imaging flow cytometry (ImageStream analysis) enables the proper identification of mono/multinuclear cell populations and provides a more complete evaluation and quantification of the phagocytosis process.
January 2:
Happy new year from the KU Leuven NanoHealth and Optical Imaging Group members
To another year of challenges, opportunities, and achievements!!!
2023 here we go!!!!
2021
January 18:
Launch of our new website. Welcome!
January:
A new review was published in Chemical Reviews providing an overview of alternative strategies to enhance nanoparticle delivery to tumor site by altering the vasculature in several ways.
Authored by Mukaddes Izci, Christy Maksoudian and Prof. Stefaan Soenen
"The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors"
2020
December 24:
Merry Christmas and a happy new year for 2021! The whole NanoHealth Group is wishing everyone good health and a more bright 2021.
August:
A new review by our group was published in Nanoscale Advances elaborating on the immunomodulatory effects of nanomaterials, with a strong focus on the underlying mechanisms that lead to these specific immune responses.
Authored by Vincent Lenders, Xanthippi Koutsoumpou, Ara Sargsian and Dr. Bella Manshian
"Biomedical nanomaterials for immunological applications: Ongoing research and clinical trials"
July:
A new open access review was published by our group in Nanoscale Advances discussing the role of inorganic nanoparticle degradation in cancer therapy.
Authored by Christy Maksoudian, Neshat Saffarzadeh, Evelien Hesemans, Nora Dekoning, Kiana Buttiens and Prof. Stefaan J. Soenen
"Role of inorganic nanoparticle degradation in cancer therapy"
April:
We our proud to share our latest publication which has been published in Bioconjugate Chem.
Authored by Christy Maksoudian, Prof. Stefeen J. Soenen and Dr. Bella Manshian
January 29-31:
Prof. Stefaan Soenen and Dr. Bella Manshian will give a talk at the 2nd International Conference on Nanomaterials Applied to Life Sciences 2020 (NALS 2020) in Madrid, Spain.
January:
Media response to our latest publication "Model-Based Nanoengineered Pharmacokinetics of Iron-Doped Copper Oxide for Nanomedical Applications" by:
January:
Our latest publication has been published in Angewandte Chemie Int. Ed. Engl.
January:
We are pleased to share that the research project of Xanthippi Koutsoumpou, with PI Dr. Bella Manshian, has been recognized by the Belgian Association for Neuro-Oncology (BANO) with the first prize! Congratulations!
2019
December 24:
Merry Christmas and a happy new year 2020 from the NanoHealth group members!
November 1:
Our PhD student Vincent Lenders will be going on a research stay at The Mitragotri Laboratory for Drug Delivery at Harvard University. The group is highly specialized in advanced drug delivery systems and inventing biomaterials for diagnostics and therapeutic applications. Vincent received a long-term travel grant from the FWO that will support his stay. We wish Vincent all the best on his Harvard adventure!
June 29-July 6:
Prof. Stefaan Soenen and Dr. Bella Manshian will give a talk at the Nanotechnology 2019 conference: workshop 3, in Thessaloniki, Greece
June 7:
Our PhD students will participate in the 16th edition of the LKI-Oncoforum 2019 at KU Leuven, Campus Gasthuisberg.
May 7:
Evelien Hesemans, Nora Dekoning, Mukaddes Izci, Neshat Saffarzadeg will attend the 3rd Research Day on Tumor Immunology and Immunotherapy at KU Leuven, Campus Gast-huisberg
March 15-19:
Evelien Hesemans will attend the 2019 Keystone Symposia on Cancer Metastasis: The Role of Metabolism, Immunity and the Microenvironment, which will take place in Florence, Italy
2018
December 24:
Merry Christmas and a happy new year for 2019 from the NanoHealth group members!
December 12:
Congratulations to Yannick Regin, Mukaddes Izci and Evelien Hesemans for obtaining their FWO-SB mandates